After receiving the ethical approval in Tanzania, NeuroSolve obtained the ethical clearance in Zambia too. The ethical clearance certificate will allow to conduct medical research on Neurocysticercosis also in Zambia.

NeuroSolve is a four-year project funded by the European Commission and EDCTP3, started on May 1, 2023. The African Institutions involved are: University of Dar es Salaam (Tanzania), Sokoine University of Agriculture (Tanzania), University of Zambia (Zambia); the European Institutions are: Universiteit Ghent (Belgium) and R-Evolution Worldwide Srl – Impresa Sociale (Italy), that is also the project Coordinator. NeuroSolve is committed to fight taeniasis/Neurocysticercosis (NCC) disease in Sub-Saharan Africa.

Potrebbe essere un'immagine raffigurante testo

Leave a Reply

Your email address will not be published. Required fields are marked *

Explore More

TB-SHIELD-WOMEN Proposal submitted to EDCTP3 call for innovative TB treatment research in sub-Saharan Africa

Our organization, together with an international consortium of partners, has submitted the project TB-SHIELD-WOMEN – Supportive nutritional Health Intervention for Enhanced recovery and Lowered Drug toxicity in vulnerable groups of

Read More

Neglected Tropical Diseases affect 1 in 5 people in the world

Neglected Tropical Diseases affect 1 in 5 people worldwide. Affecting over 1.7 billion people, the Neglected Tropical Diseases impair physical and cognitive development, contribute to mother and child illness and

Read More

EXCO2019, the first and only global expo dedicated to the players active in the field of development cooperation

R-Evolution Worldwide Community Interest Company joined in EXCO2019, the first and only global expo dedicated to the innovative solutions provided by the actors of development cooperation: national and international agencies,

Read More